Predicting the outcome of treatment
Journal of Abnormal Child Psychology
|May 5, 1998
Summary
Predicting treatment success in pediatric anxiety and obsessive-compulsive disorder (OCD) requires analyzing patient characteristics and treatment variables. This study proposes a framework for improving treatment outcome prediction through rigorous study designs and predictor variable analysis.
Area of Science:
- Clinical Psychology
- Psychiatry
- Biostatistics
Background:
- Differential therapeutics aims to match treatments to patients based on specific characteristics and mechanisms.
- Predicting treatment outcomes is crucial for optimizing therapeutic strategies in mental health.
Purpose of the Study:
- To discuss the challenges and methods for predicting treatment outcomes in clinical studies.
- To propose a framework for identifying and analyzing predictor variables in treatment outcome research, using pediatric anxiety and obsessive-compulsive disorder (OCD) as examples.
Main Methods:
- Utilizing the general linear model for prediction analysis.
- Outlining study designs for testing potential predictors of treatment outcomes.
- Presenting a matrix of predictor variables from an NIMH-funded study on pediatric OCD.
Main Results:
- The study frames treatment outcome prediction as a testable hypothesis within the general linear model.
- A matrix of predictor variables for pediatric OCD treatment is proposed.
- The importance of defining terms and utilizing moderating and mediating variables in prediction is highlighted.
Conclusions:
- A broader approach to studying predictors is recommended for enhancing treatment outcome prediction.
- Improved prediction models can lead to more personalized and effective therapeutic interventions.
- Further research should focus on implementing and validating these predictor frameworks in diverse clinical populations.
Related Concept Videos
02:07Blind Procedures
Ideally, the people who observe and record the children’s behavior are unaware of who was assigned to the experimental or control group, in order to control for experimenter bias. Experimenter bias refers to the possibility that a researcher’s expectations might skew the results of the study. Remember, conducting an experiment requires a lot of planning, and the people involved in the research project have a vested interest in supporting their hypotheses. If the observers knew which child was...
01:52Regression Toward the Mean
Regression toward the mean (“RTM”) is a phenomenon in which extremely high or low values—for example, and individual’s blood pressure at a particular moment—appear closer to a group’s average upon remeasuring. Although this statistical peculiarity is the result of random error and chance, it has been problematic across various medical, scientific, financial and psychological applications. In particular, RTM, if not taken into account, can interfere when researchers try to extrapolate results...
01:11Blinding
Blinding is a commonly used method of not telling participants which treatment a subject is receiving. Blinding is a critical part of a randomized control trial or RCT. It reduces the bias that affects the results. In an RCT, blinding is used in the form of a placebo. A placebo effect occurs when untreated subjects falsely believe they have received the treatment and report improved symptoms. A placebo or a dummy treatment is administered to subjects to negate the bias caused by such an effect.
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
01:29Therapeutic Drug Monitoring: Affecting Factors
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
01:21Cancer Survival Analysis
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...